Probi 2012 sales up 6%, but ProViva royalties set for dive
The European probiotic sector is bracing itself for tough times ahead in the wake of December’s EU health claim ban for the sector, but the effects are yet to be felt at Swedish supplier Probi which notched 6% sales growth in 2012.